How fast can you lose weight on semaglutide?

Step 1 — the first four weeks: your body adjusting, not yet transforming

Semaglutide treatment begins at 0.25mg, a starting dose designed to let your system settle rather than deliver immediate fat loss. At this level, appetite suppression is mild. Some people notice they feel full a little sooner at meals; others notice almost nothing yet. Weight change in week one or two is usually modest — a kilogram or two at most, sometimes less.

The GLP-1 receptor agonist mechanism works by slowing gastric emptying and signalling satiety to the brain, which reduces overall calorie intake over time. That process takes several weeks to compound into visible change. If you begin treatment and expect dramatic results within the first fortnight, you are likely to feel underwhelmed. The first pen's job is adjustment, not transformation.

Practically, this matters for how you plan. Starting in January because of a holiday in May is a reasonable window. Starting the week before a big trip and hoping to drop a dress size is not. Our page on how long Wegovy takes to work goes deeper on what to expect in those opening weeks.

Step 2, months two to six: dose titration and accelerating loss

This is where most people start to see consistent downward movement on the scales. The dose increases roughly every four weeks (0.25mg → 0.5mg → 1.0mg → 1.7mg → 2.4mg), and each step typically brings stronger appetite suppression. By month three or four, many people are eating noticeably less without feeling deprived, because semaglutide reduces the reward signal around food rather than just making you feel hungry and miserable.

In the STEP 1 trial, participants lost an average of around 6% of body weight by week 20, with losses continuing to accumulate through to week 68. That trajectory (slow start, accelerating middle, plateau-approaching end) is the typical arc. If you started on a Tuesday in February and are reading this in April wondering whether it is working, the data suggest you may simply be in the early part of the curve.

The timeline for weight loss on semaglutide depends heavily on how smoothly your titration goes. People who need to pause dose increases because of side effects will move along this curve more slowly, which is clinically appropriate, not a failure.

Step 3, months six to eighteen: maintenance dose and the bulk of results

Once at 2.4mg (or the newer 7.2mg dose, where clinically suitable), weight loss continues but the rate gradually slows as the body reaches a new equilibrium. The STEP 1 trial ran to 68 weeks; the average loss of approximately 15% was driven largely by what happened in this later phase, with participants on the 2.4mg dose continuing to lose weight well past the six-month mark. You can read the full trial data via STEP 1, published in the New England Journal of Medicine.

The MHRA approved a dedicated single-dose 7.2mg Wegovy pen in April 2026 for adults with a BMI of 30 or above. Early trial data suggest around 20.7% average weight loss at this dose over 72 weeks, which meaningfully narrows the gap with tirzepatide. Whether this dose is right for an individual is a prescriber decision; our Wegovy overview covers how the full titration pathway works in practice.

For context on how semaglutide's results compare with other medicines, the average weight-loss percentage across the semaglutide programme is a useful reference. NICE's recommendation for semaglutide (TA875) notes that treatment should be reviewed if less than 5% weight loss is achieved after six months on the maintenance dose, a clear clinical benchmark for both patients and prescribers.

Why your pace may differ from the trial average

Clinical trial participants follow strict protocols, attend regular appointments and receive structured dietary support. Real-world results often show slightly more variation. Factors that influence how fast you lose weight on Wegovy include how close you are to your metabolic set-point, whether you have type 2 diabetes (which tends to slow weight loss compared with people without it), sleep quality, stress levels and whether protein and fibre intake remain adequate as overall calories fall.

Side effects also play a role. Nausea, the most commonly reported, peaks in the first week or two after a dose increase and usually settles. Managing it well (smaller portions, avoiding rich or fatty foods, staying hydrated) means you are less likely to need a dose pause, which in turn keeps your timeline on track. A fuller picture of what to expect over the full course of treatment is in our guide on how long you can stay on semaglutide.

One thing worth knowing: semaglutide is a prescription-only medicine, and the question of which dose you should be at, and when, is answered by a prescriber reviewing your progress, not by guesswork or a forum post. If you want to understand whether you are a candidate for this treatment, check your eligibility with our clinical team, the consultation is free and reviewed the same day by a GPhC-registered prescriber.